Tech Company Financing Transactions
Heartflow Funding Round
On 4/6/2023, Heartflow raised $215 million in Series F funding from Bain Capital Life Sciences, Baillie Gifford and Capricorn Investment Group.
Transaction Overview
Company Name
Announced On
4/6/2023
Transaction Type
Venture Equity
Amount
$215,000,000
Round
Series F
Investors
Proceeds Purpose
The company intends to use the funds to extend the demand for its commercial products, support clinical evidence and advance its comprehensive product portfolio.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1400 Seaport Blvd. Bldg B
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Non-invasive coronary artery disease detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dana Mead
Chief Medical Officer
Campbell Rogers
Chief Technical Officer
Charles Taylor
VP - Bus. Development
Lance Scott
VP - General Counsel
Noemi Espinosa
VP - Human Resources
Renata Naoumov
Browse more venture capital transactions:
Prev: 4/6/2023: Invincibles Studio venture capital transaction
Next: 4/6/2023: Alga Biosciences venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs